261 related articles for article (PubMed ID: 15983204)
1. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice.
Wong FS; Du W; Thomas IJ; Wen L
Diabetes; 2005 Jul; 54(7):2032-40. PubMed ID: 15983204
[TBL] [Abstract][Full Text] [Related]
2. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
4. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
6. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells.
Wong FS; Visintin I; Wen L; Flavell RA; Janeway CA
J Exp Med; 1996 Jan; 183(1):67-76. PubMed ID: 8551245
[TBL] [Abstract][Full Text] [Related]
7. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
[TBL] [Abstract][Full Text] [Related]
8. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
[TBL] [Abstract][Full Text] [Related]
9. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
Serreze DV; Gaskins HR; Leiter EH
J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
[TBL] [Abstract][Full Text] [Related]
10. CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice.
Yoneda R; Yokono K; Nagata M; Tominaga Y; Moriyama H; Tsukamoto K; Miki M; Okamoto N; Yasuda H; Amano K; Kasuga M
Diabetologia; 1997 Sep; 40(9):1044-52. PubMed ID: 9300241
[TBL] [Abstract][Full Text] [Related]
11. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
Wen L; Chen NY; Tang J; Sherwin R; Wong FS
J Clin Invest; 2001 Apr; 107(7):871-80. PubMed ID: 11285306
[TBL] [Abstract][Full Text] [Related]
12. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
14. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
15. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.
Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939
[TBL] [Abstract][Full Text] [Related]
16. Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice.
Sumida T; Furukawa M; Sakamoto A; Namekawa T; Maeda T; Zijlstra M; Iwamoto I; Koike T; Yoshida S; Tomioka H
Int Immunol; 1994 Sep; 6(9):1445-9. PubMed ID: 7819154
[TBL] [Abstract][Full Text] [Related]
17. Expression of the B7.1 costimulatory molecule on pancreatic beta cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes.
Havari E; Lennon-Dumenil AM; Klein L; Neely D; Taylor JA; McInerney MF; Wucherpfennig KW; Lipes MA
J Immunol; 2004 Jul; 173(2):787-96. PubMed ID: 15240665
[TBL] [Abstract][Full Text] [Related]
18. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
Kay TW; Parker JL; Stephens LA; Thomas HE; Allison J
J Immunol; 1996 Oct; 157(8):3688-93. PubMed ID: 8871671
[TBL] [Abstract][Full Text] [Related]
19. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
